Andembry Disease Interactions
There is 1 disease interaction with Andembry (garadacimab).
Moderate
Garadacimab (applies to Andembry) renal dysfunction
Moderate Potential Hazard, Moderate plausibility.
The effect of severe renal impairment (estimated GFR less than 30 mL/min/1.73 m2) on garadacimab pharmacokinetics is unknown. Exposure to garadacimab was not significantly affected in patients with mild to moderate renal dysfunction.
References (1)
- (2025) "Product Information. Andembry Prefilled Autoinjector (garadacimab)." CSL Behring LLC
Switch to consumer interaction data
Andembry drug interactions
There are 3 drug interactions with Andembry (garadacimab).
Report options
QR code containing a link to this page
More about Andembry (garadacimab)
- Andembry consumer information
- Check interactions
- Compare alternatives
- Drug images
- FDA approval history
- Drug class: hereditary angioedema agents
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
